Ving J. Lee
Plus aucun poste en cours
Profil
Ving J.
Lee is the founder of Limerick BioPharma, Inc. He previously worked as the Director at PharmaRoth Labs, Inc., Vice President-Chemistry & Pre-clinical Research at Essential Therapeutics, Inc., Principal at Iconix Biosciences, Inc., Chief Scientific Officer & VP-Discovery Research at Anacor Pharmaceuticals LLC, and Principal at Lederle Laboratories.
He also served as the Chief Executive & Scientific Officer at Adesis, Inc. Dr. Lee completed his undergraduate degree at The Ohio State University and his graduate and doctorate degrees at the University of Illinois.
Anciens postes connus de Ving J. Lee
| Sociétés | Poste | Fin |
|---|---|---|
| ANACOR PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | 01/01/2004 |
Adesis, Inc.
 Adesis, Inc. Chemicals: SpecialtyProcess Industries Adesis, Inc. operates as a contract research organization that supports the pharmaceutical and biopharmaceutical industry, biomaterials, and catalysts industry. The firm specializes in organic and organometallic synthesis in milligrams to multi-kilogram quantities. Its services include custom synthesis, research and development, and specialty manufacturing services. The company was founded by Andrew Cottone in 2005 and is headquartered in New Castle, DE. | Directeur Général | - |
Lederle Laboratories
 Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Corporate Officer/Principal | - |
| PHARMAROTH LABS, INC. | Directeur/Membre du Conseil | - |
Essential Therapeutics, Inc.
 Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections | Directeur Technique/Scientifique/R&D | - |
Formation de Ving J. Lee
| The Ohio State University | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PHARMAROTH LABS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Essential Therapeutics, Inc.
Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections | Health Technology |
Iconix Biosciences, Inc.
 Iconix Biosciences, Inc. BiotechnologyHealth Technology Iconix Biosciences is a multi-disciplinary company that integrates the skills and knowledge necessary for the creation of the world's largest toxicogenomics database of microarray and pharmacology data (DrugMatrix) with the informatics expertise and computer skills required to mine and interpret this vast body of information. Based on the data in DrugMatrix, Iconix has developed a library of Drug Signatures, genomic biomarkers that are predictive of specific toxicological endpoints and mechanisms of action. DrugMatrix and Drug Signatures provide a uniform source of molecular toxicology information, analytical tools, data mining algorithms and biomarkers to optimize drug candidates and predict their potential efficacy and toxicity before they advance to expensive preclinical and clinical development studies. Iconix's platform includes an integrated database architecture (IXIS) to bridge genomics and drug design, novel bio and chemoinformatics software, and advanced expression array and cellular expression assay development capabilities. This technology platform is coupled with an unparalled group of molecular toxicologists and bioinformaticians with years of experience in applying the tools and contextual data to provide clients with answers to critical scientific questions. Iconix has focused these capabilities on a line of products, licenses, services, and long-term collaborations. Iconix provides reports on customer compounds to classify them and help prioritize and select the best leads for advancement at all stages of discovery. Iconix has also entered exclusive alliances with collaborators to apply toxicogenomics data and know-how to customized drug discovery and development projects. Founded in 1998 by distinguished scientists and pharmaceutical industry professionals, Iconix has won the backing of some of the highest profile venture capitalists in the biotechnology and information technology industries. Iconix has also established alliances with leading global technology companies for the development and commercialization of its products, including MDS Pharma Services, Spotfire, Amersham Biosciences, MDL Information Systems, and Affymetrix. | Health Technology |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Limerick BioPharma, Inc.
 Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Limerick BioPharma is dedicated to the discovery and development of novel small molecule product candidates to address areas of significant unmet medical need. Their intent is to bring forth innovative therapies that have the potential to change treatment paradigms via their enhanced safety and / or efficacy profiles. Limerick is developing novel products that can enhance the safety of existing therapeutic agents or function as innovative stand-alone therapies. Their lead programs are in the areas of metabolic diseases and solid organ transplantation. In metabolic diseases, their programs are in clinical development for treatment of diabetes and dyslipidemia. For transplant indications, their programs are in clinical development as adjunctive therapy to treat metabolic dysregulation induced by leading immunosuppressants. Beyond these first-generation programs, Limerick has developed a proprietary and cutting-edge discovery platform that can be leveraged for other high-need, high-value areas. They intend to maximize the value of their product candidates and discovery platform through independent development, licensing and other partnership opportunities. | Health Technology |
Lederle Laboratories
Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Commercial Services |
Adesis, Inc.
Adesis, Inc. Chemicals: SpecialtyProcess Industries Adesis, Inc. operates as a contract research organization that supports the pharmaceutical and biopharmaceutical industry, biomaterials, and catalysts industry. The firm specializes in organic and organometallic synthesis in milligrams to multi-kilogram quantities. Its services include custom synthesis, research and development, and specialty manufacturing services. The company was founded by Andrew Cottone in 2005 and is headquartered in New Castle, DE. | Process Industries |
